登录 注册 会员服务 联系我们

Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review

  • Published:2024-09-10 Issue: Volume: Page:
  • ISSN:1530-7905
  • Container-title:Cardiovascular Toxicology
  • language:en
  • Short-container-title:Cardiovasc Toxicol

Author:

Tan Sihan,Qi Chang,Zeng Hao,Wei Qi,Huang Qin,Pu Xin,Li Weimin,Li Yalun,Tian Panwen

Funder

National Natural Science Foundation of China

Science and Technology Project of Sichuan, China

1-3-5 project for disciplines of excellence

Publisher

Springer Science and Business Media LLC

Reference99 articles.

1. Diesendruck, Y., & Benhar, I. (2017). Novel immune check point inhibiting antibodies in cancer therapy-opportunities and challenges. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, 30, 39–47. https://doi.org/10.1016/j.drup.2017.02.001

2. Schneider, B. J., Naidoo, J., Santomasso, B. D., Lacchetti, C., Adkins, S., Anadkat, M., & Bollin, K. (2021). Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 39(36), 4073–4126. https://doi.org/10.1200/JCO.21.01440

3. Puzanov, I., Diab, A., Abdallah, K., Bingham, C. O., Brogdon, C., Dadu, R., Society for Immunotherapy of Cancer Toxicity Management Working Group. (2017). Managing toxicities associated with immune checkpoint inhibitors: Consensus recommendations from the society for immunotherapy of cancer (SITC) toxicity management working group. Journal for Immunotherapy of Cancer, 5(1), 95. https://doi.org/10.1186/s40425-017-0300-z

4. Michot, J. M., Bigenwald, C., Champiat, S., Collins, M., Carbonnel, F., Postel-Vinay, S., & Lambotte, O. (2016). Immune-related adverse events with immune checkpoint blockade: A comprehensive review. European Journal of Cancer, 54, 139–148. https://doi.org/10.1016/j.ejca.2015.11.016

5. Ganatra, S., & Neilan, T. G. (2018). Immune checkpoint inhibitor-associated myocarditis. The Oncologist, 23(8), 879–886. https://doi.org/10.1634/theoncologist.2018-0130
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3